HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhi Peng Selected Research

Aspartate Aminotransferases (Aspartate Transaminase)

1/2023Phase Ib study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis.
11/2021Efficacy and safety of a novel anti-HER2 therapeutic antibody RC48 in patients with HER2-overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single-arm phase II study.
1/2021Transarterial Chemoembolization Combined With Endoscopic Therapy Is Beneficial for Unresectable Hepatocellular Carcinoma With Esophagogastric Varices.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhi Peng Research Topics

Disease

45Neoplasms (Cancer)
07/2024 - 01/2009
28Stomach Neoplasms (Stomach Cancer)
05/2024 - 01/2014
17Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2024 - 01/2019
10Adenocarcinoma
01/2023 - 01/2020
9Microsatellite Instability
01/2024 - 01/2020
9Colorectal Neoplasms (Colorectal Cancer)
04/2022 - 01/2019
5BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2020 - 12/2005
5Leukemia
06/2012 - 01/2004
3Inflammation (Inflammations)
04/2024 - 09/2011
3Hypertension (High Blood Pressure)
02/2023 - 01/2022
3Infections
10/2022 - 01/2021
3Circulating Neoplastic Cells
10/2021 - 11/2017
3Hepatocellular Carcinoma (Hepatoma)
01/2021 - 01/2011
3Melanoma (Melanoma, Malignant)
10/2020 - 03/2019
3Chronic Hepatitis B
01/2019 - 05/2013
3Neoplasm Metastasis (Metastasis)
03/2018 - 04/2015
2Liver Neoplasms (Liver Cancer)
05/2023 - 01/2011
2Sarcopenia
01/2023 - 12/2022
2Colitis
01/2023 - 01/2022
2Anemia
01/2022 - 11/2021
2Neutropenia
01/2022 - 01/2021
2Neuroendocrine Carcinoma
01/2022 - 01/2020
2Hemorrhage
06/2021 - 01/2021
2Esophageal Neoplasms (Esophageal Cancer)
08/2020 - 01/2013
2Esophageal Squamous Cell Carcinoma
01/2019 - 01/2015
1Hypoxia (Hypoxemia)
07/2024
1Breast Neoplasms (Breast Cancer)
07/2024
1Hemarthrosis
05/2024
1Fatigue
01/2024
1Dental Caries (Decay, Dental)
01/2024
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2024
1Cough
01/2024
1Acute Disease
11/2023
1Necrosis
11/2023
1Lipid Metabolism Disorders (Metabolism Disorders, Lipid)
10/2023
1Acute-Phase Reaction
10/2023
1Fatty Liver
10/2023
1Endophthalmitis (Ophthalmia)
08/2023

Drug/Important Bio-Agent (IBA)

28Immune Checkpoint InhibitorsIBA
01/2024 - 01/2019
19Biomarkers (Surrogate Marker)IBA
05/2024 - 05/2016
11Proteins (Proteins, Gene)FDA Link
01/2024 - 01/2004
7Tyrosine Kinase InhibitorsIBA
05/2024 - 09/2014
6LigandsIBA
01/2024 - 11/2015
5CytokinesIBA
04/2024 - 09/2011
3toripalimabIBA
02/2024 - 01/2020
3Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2023 - 01/2021
3RNA (Ribonucleic Acid)IBA
12/2022 - 10/2021
3human ERBB2 proteinIBA
04/2022 - 04/2015
3Messenger RNA (mRNA)IBA
01/2022 - 06/2011
3HMPL-013IBA
01/2022 - 02/2020
3regorafenibIBA
01/2022 - 02/2020
3Irinotecan (Camptosar)FDA LinkGeneric
01/2022 - 01/2013
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2017 - 11/2004
3Trastuzumab (Herceptin)FDA Link
05/2016 - 09/2015
2BilirubinIBA
02/2023 - 01/2021
2B7-H1 AntigenIBA
01/2023 - 01/2020
2Interleukin-6 (Interleukin 6)IBA
01/2022 - 09/2011
2Fluorouracil (Carac)FDA LinkGeneric
01/2022 - 09/2014
2130-nm albumin-bound paclitaxelIBA
05/2021 - 01/2020
2GemcitabineFDA Link
05/2021 - 01/2020
2Tumor Biomarkers (Tumor Markers)IBA
01/2020 - 01/2015
2Cisplatin (Platino)FDA LinkGeneric
01/2020 - 09/2014
2ParaffinIBA
11/2015 - 08/2012
2Antiviral Agents (Antivirals)IBA
06/2014 - 05/2013
2Imatinib Mesylate (Gleevec)FDA Link
06/2012 - 05/2011
2Small Interfering RNA (siRNA)IBA
11/2004 - 01/2004
1PolymersIBA
07/2024
1ChitosanIBA
07/2024
1CarbohydratesIBA
07/2024
11- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazineIBA
05/2024
1capmatinibIBA
05/2024
1CrizotinibIBA
05/2024
1tepotinibIBA
05/2024
1Collagen Type II (Type II Collagen)IBA
05/2024
1FlavonoidsIBA
04/2024
1Immunoconjugates (Immunoconjugate)IBA
02/2024
1zolbetuximabIBA
01/2024
1ClaudinsIBA
01/2024
1Bombesin Receptors (Bombesin Receptor)IBA
01/2024
1Anti-Allergic Agents (Antiallergic Agents)IBA
01/2024
1Imiquimod (Aldara)FDA LinkGeneric
01/2024
1LipidsIBA
01/2024
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2024
1ChemokinesIBA
01/2024
1Retinaldehyde (Retinal)IBA
11/2023
1Fibroins (Fibroin)IBA
10/2023
1Polypropylenes (Polypropylene)IBA
10/2023
1Biocompatible Materials (Biomaterials)IBA
10/2023
1Voriconazole (Vfend)FDA LinkGeneric
08/2023
1Antineoplastic Agents (Antineoplastics)IBA
05/2023
1gadolinium-bovine serum albumin complexIBA
05/2023
1Epithelial Cell Adhesion MoleculeIBA
05/2023
1cupric sulfide (CuS)IBA
05/2023
1Transaminases (Aminotransferases)IBA
02/2023

Therapy/Procedure

30Therapeutics
01/2024 - 05/2011
24Immunotherapy
04/2024 - 07/2019
18Drug Therapy (Chemotherapy)
07/2024 - 01/2013
2Neoadjuvant Therapy
01/2023 - 01/2021
1Lasers (Laser)
07/2024
1Photothermal Therapy
05/2023